US 8334301
5-Membered heterocyclic compound
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8334301 (5-Membered heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P35/00, A61P43/00